Industry tells Congress incentives needed to boost domestic drug manufacturing
Regulatory NewsJoanne S. Eglovitch
Antimicrobial resistanceAPIsBiologics/ biosimilars/ vaccinesCoronavirus/COVID-19GenericsPharmaceuticalsProduct developmentProject managementPublic healthRegulatory strategyShortagesSupply Chain ManagementUnited States